Filter
717
Text search:
pooled
testing
Featured
Recommendations
73
New Publications
169
Language
Document type
No document type
347
Studies & Reports
146
Guidelines
119
Strategic & Response Plan
38
Manuals
31
Fact sheets
16
Training Material
9
Situation Updates
6
Infographics
3
Resource Platforms
1
Countries / Regions
Global
36
India
27
Ethiopia
24
Kenya
22
Zambia
19
Nigeria
18
Zimbabwe
15
Nepal
15
Tanzania
14
Malawi
14
Africa
14
Uganda
12
South Africa
12
Sierra Leone
9
Namibia
9
Latin America and the Carribbean
9
Western and Central Europe
9
Liberia
8
Ghana
8
Mozambique
8
Rwanda
6
Lesotho
6
Myanmar / Burma
6
South–East Asia Region
6
Congo, Democratic Republic of
5
Botswana
5
Senegal
4
Cameroon
4
Philippines
4
South Sudan
4
Syria
4
Ukraine
4
East and Southern Africa
4
Asia
4
Guinea
3
Burkina Faso
3
Mali
3
Pakistan
3
Jordan
3
Afghanistan
3
Germany
3
Turkey
3
Cambodia
3
Bangladesh
3
Peru
3
Eswatini/ Swaziland
3
USA
2
Somalia
2
Egypt
2
Thailand
2
Indonesia
2
Sudan
2
Brazil
2
Yemen
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Eastern Europe
2
Moldova
2
North America
2
Côte d’Ivoire / Ivory Coast
1
Haiti
1
Iraq
1
Lebanon
1
Chad
1
Benin
1
Central African Republic
1
Dominican Republic
1
Burundi
1
Colombia
1
Honduras
1
Angola
1
Madagascar
1
West and Central Africa
1
Middle East and North Africa
1
Venezuela
1
Djibouti
1
Southern Africa
1
Russia
1
Iran
1
Georgia
1
Vietnam
1
Gabon
1
France
1
Mauritius
1
United Kingdom
1
Portugal
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
240
Clinical Guidelines
100
Public Health
39
Women & Child Health
29
Key Resources
19
Pharmacy & Technologies
18
Capacity Building
1
Toolboxes
HIV
110
COVID-19
83
TB
71
AMR
35
Mental Health
30
NTDs
20
Planetary Health
13
Health Financing Toolbox
13
NCDs
13
Pharmacy
12
Disability
10
Conflict
10
Caregiver
10
Malaria
10
Rapid Response
9
Refugee
9
2.0 Rapid Response
8
Global Health Education
7
Ebola & Marburg
4
Cholera
3
Polio
2
Zika
2
South Sudan
1
Social Ethics
1
This document highlights the latest WHO recommendations designed to optimize health outcomes, streamline delivery and address persistent barriers to prevention and care. It especially focuses on people often left behind in service delivery, including adolescents and young people, key populations and
...
This manual describes some of the strategic, managerial, financial, technical and scientific aspects to be considered in establishing a national EQA programme for clinical laboratories and other testing services at all health care levels
Adapting HIV testing services in the context of reduced and declining funding. Presentation May 2025
A survey of prevention, testing and treatment policies and practices
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of
...
The provision of safe and efficacious blood and blood components for transfusion or manufacturing use involves a number of processes, from the selection of blood donors and the collection, processing and testing of blood donations to the
...
Antimicrobial Resistance Surveillance and Research Network | This manual describes well accepted methods to carry out drug susceptibility testing on important gram positive and gram negative clinically relevant bacteria. Methods of specimen collecti
...
HUMANITIES AND SOCIAL SCIENCES COMMUNICATIONS | (2022)9:295 | https://doi.org/10.1057/s41599-022-01312-3 .
Sub-Saharan Africa (SSA), particularly Southern and East Africa, has the highest AIDS deaths
and HIV-infected people in the world. Even though considerable effort has been made over
the yea
...
Updated recommendations on simplified service delivery and diagnostics for hepatitis C infection
recommended
Policy Brief. 24 June 2022. This policy brief, one of two on the updated hepatitis C (HCV) guidelines, focuses on the new recommendations on simplified service delivery for a public health approach to HCV testing, care and treatment. These recommend
...
Antimicrobial Resistance Surveillance and Research Network | This document contains detail procedures on sample collection, transport, isolation, identification of fungi for the diagnosis of invasive fungal infections and antifungal susceptibility testing
...
This version of Field Trials of Health Interventions includes seven new chapters on conducting systematic literature reviews, trial
governance, preliminary studies and pilot testing, budgeting and accounting, intervention costing and economic analy
...
Following review of the latest evidence, WHO recommends that TB-LAMP can be used as a replacement for microscopy for the diagnosis of pulmonary TB in adults with signs and symptoms of TB. It can also be considered as a follow-on test to microscopy in adults with signs and symptoms of pulmonary TB, e
...
Clinical guideline, Methods, Evidence and Recommendations
In this guideline the following is covered: information needs of people with chronic hep
titis B and their carers; where children, young people and adults with chronic hepatitis B a-
should be assessed; assessment of liver disease, includi
...
Sudan recorded the first COVID-19 case on 13 March 2020 and, at the beginning of July, the Federal Ministry of Health had confirmed that nearly 10,000 people had contracted the virus, including over 600 who died from the disease across the country. Although more than 70 per cent of the confirmed cas
...
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance
...
WHO has a unique combination of technical public health and scientific expertise, and a global operational footprint, with field offices in more than 150 countries. In 2020, this global, technical, and operational reach meant WHO was able to support countries around the world in every aspect of COVI
...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im
...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a
...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im
...
